Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Budesonide Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115819487A details a novel 4-step synthesis of 16α-hydroxyprednisolone from tetraene acetate, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.
Novel synthesis route for budesonide intermediate offering high yield and scalable production for pharmaceutical supply chains and cost efficiency.
Patent CN109651474A reveals a novel route for 16a-hydroxy prednisonlone. Enhanced yield and purity offer significant supply chain and cost advantages.